Petros Pharmaceuticals Faces Default Event, Forced Partial Repayment of Obligations
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) encountered a default event, necessitating immediate repayment of outstanding obligations. As outlined in a recent 8-K filing with the Securities and Exchange Commission dated December 10, 2024, the company’s subsidiary, Metuchen Pharmaceuticals LLC, defaulted on a payment due on October 1, 2024, which triggered the acceleration of obligations. The default event […]
More Stories
Hertz Global (OTCMKTS:HTZZ) Hits New 52-Week Low – Time to Sell?
Hertz Global Holdings, Inc. (OTCMKTS:HTZZ – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday...
Ouster, Inc. (NYSE:OUST) CFO Sells $191,009.28 in Stock
Ouster, Inc. (NYSE:OUST – Get Free Report) CFO Mark Weinswig sold 19,712 shares of Ouster stock in a transaction dated...
Insider Selling: Peyto Exploration & Development Corp. (TSE:PEY) Director Sells 4,797 Shares of Stock
Peyto Exploration & Development Corp. (TSE:PEY – Get Free Report) Director Stephen Jonathan Chetner sold 4,797 shares of Peyto Exploration...
North European Oil Royalty Trust (NYSE:NRT) Short Interest Down 21.7% in November
North European Oil Royalty Trust (NYSE:NRT – Get Free Report) was the recipient of a significant drop in short interest...
RF Acquisition Corp. (NASDAQ:RFAC) Sees Large Decline in Short Interest
RF Acquisition Corp. (NASDAQ:RFAC – Get Free Report) was the target of a large decrease in short interest in the...
Flight Centre Travel Group Limited (OTCMKTS:FGETF) Short Interest Down 17.4% in November
Flight Centre Travel Group Limited (OTCMKTS:FGETF – Get Free Report) saw a significant drop in short interest in the month...